[1]
M. Cao, Q. Lin, L. Lin, W. Zhang, and L. Zhang, “The Efficacy and Safety of Empagliflozin in Elderly Patients with Type 2 Diabetes Mellitus Complicating Cardiorenal Syndromes Type II and IV: Evaluation of Empagliflozin in CRS”, J Med Biochem, vol. 44, no. 4, pp. 905–914, Apr. 2025, doi: 10.5937/jomb0-54743.